Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: moose who wrote (8651)	5/28/1998 7:35:00 PM
From: Frostman	Read Replies (1) \| Respond to of 23519

Mooseman, The company is ICOS, the drug's working name is IC351.

To: moose who wrote (8651)	5/28/1998 7:43:00 PM
From: DaiS	Respond to of 23519

Moose, There was a piece in the Times today. A small Danish company, Hansen, supported by Glaxo have what appears to be a sildenafil derivative that does not infringe the Pfizer patent and the drug can does not have to be used systemically. Might be ready in a couple of months. At least if we lose all our Vivus money we will have the satisfaction that the curse of ED is banished from the world. DaiS

To: moose who wrote (8651)	5/28/1998 7:49:00 PM
From: DaiS	Respond to of 23519

Moose, No just ignore my message 8654. I just don't want to hear about any more drugs that might hurt Vivus - so what is this drug from ICOS. DaiS

To: moose who wrote (8651)	5/28/1998 8:00:00 PM
From: VLAD	Read Replies (2) \| Respond to of 23519

moose, This other drug has already been discussed in the past and it still is a long way from being on the market. Just another Powderject type of story we have been hearing about. I was told by Vivus that research was being done on a Viagra like compound to see if it could be delivered by Vivus's patented transurethral delivery system. Maybe this is the drug and company that Vivus is working with. If so, then this type of news is good news for Vivus.